May 3, 2023Open Access

Evaluation of Waning of SARS-CoV-2 Vaccine–Induced Immunity

Puntos clave

Los puntos clave no están disponibles para este artículo en este momento.

Resumen

These findings suggest that the effectiveness of COVID-19 vaccines against laboratory-confirmed Omicron or Delta infection and symptomatic disease rapidly wanes over time after the primary vaccination cycle and booster dose. These results can inform the design of appropriate targets and timing for future vaccination programs.

Me gusta

Guardar

Ver artículo completo

Cite This Study

Menegale et al. (Wed,) studied this question.

synapsesocial.com/papers/69d747718e958094d1b8aaca https://doi.org/https://doi.org/10.1001/jamanetworkopen.2023.10650

Also Consider

Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context:

1Long-term effectiveness of COVID-19 vaccines against infections, hospitalisations, and mortality in adults: findings from a rapid living systematic evidence synthesis and meta-analysis up to December, 20222023 · 296 citations
2Vaccine effectiveness against SARS-CoV-2 infection or COVID-19 hospitalization with the Alpha, Delta, or Omicron SARS-CoV-2 variant: A nationwide Danish cohort study2022 · 155 citations
3Waning Effectiveness of the BNT162b2 Vaccine Against Infection in Adolescents2022 · 19 citations

Me gusta

Guardar

Ver artículo completo